Concepts in Cardio-Oncology: Definitions, Mechanisms, Diagnosis and Treatment Strategies of Cancer Therapy-Induced Cardiotoxicity
Key result
Cancer therapies cause significant cardiotoxicity requiring multidisciplinary cardio-oncology care for early detection and management.
Why the study?
Improved cancer survival has made short- and long-term cardiotoxic effects of cancer therapy more apparent, prompting the need to identify high-risk patients for early surveillance, treatment, and follow-up.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports cardio-oncology integration for cancer survivors; leaves open optimal surveillance protocols pending prospective trials.
Key Points
- This research aims to define cardiotoxic effects of cancer treatments and to develop strategies for early intervention.
- Review of cardiotoxicity mechanisms related to anticancer agents.
- Evaluation of diagnostic advances and preventative approaches in cardio-oncology.
- Identification of high-risk patients for tailored surveillance plans.
- Increased recognition of cardiotoxicity in long-term cancer survivors.
- Effective early surveillance strategies improve patient management.
- Recent advances enhance early detection and prevention of cardiac complications.
PICO
P
Population
Cancer therapy-induced cardiotoxicity
E
Exposure / Comparator
Cancer therapy
This review outlines the mechanisms of cancer therapy-induced cardiotoxicity and highlights the role of multimodality imaging, particularly echocardiography and cardiac MRI, in early detection and surveillance.
Limitations
- Current recommendations are based on relatively small studies, retrospective data, and consensus statements
- Lack of large-scale prospective randomized trials to evaluate the clinical efficacy of pharmacologic interventions
Cite This Study
Wickramasinghe et al. (2016) conducted a review in Cancer therapy-induced cardiotoxicity. Cancer therapy was evaluated. Cancer therapies, including anthracyclines and targeted agents, can cause significant cardiotoxicity, necessitating multidisciplinary cardio-oncology care for early detection and management.